vanadates has been researched along with Diabetes Mellitus, Gestational in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| al-Attas, OS; al-Dagheri, NM; Vigo, NT | 1 |
| Catalano, PM; Friedman, JE; Ishizuka, T; Shao, J; Yamashita, H | 1 |
2 other study(ies) available for vanadates and Diabetes Mellitus, Gestational
| Article | Year |
|---|---|
Vanadate enhances insulin-receptor binding in gestational diabetic human placenta.
Topics: Adult; Blood Glucose; Diabetes Mellitus; Diabetes, Gestational; Female; Fructosamine; Hexosamines; Humans; Insulin; Placenta; Pregnancy; Protein Binding; Receptor, Insulin; Risk Factors; Stimulation, Chemical; Vanadates | 1995 |
Vanadate enhances but does not normalize glucose transport and insulin receptor phosphorylation in skeletal muscle from obese women with gestational diabetes mellitus.
Topics: Biological Transport; Diabetes, Gestational; Female; Glucose; Humans; Insulin Receptor Substrate Proteins; Muscle, Skeletal; Obesity; Phosphoproteins; Phosphorylation; Pregnancy; Pregnancy Complications; Protein Tyrosine Phosphatase, Non-Receptor Type 1; Protein Tyrosine Phosphatases; Receptor, Insulin; Reference Values; Tyrosine; Vanadates | 2000 |